CAU
LH icon

Caxton Associates (UK)’s Labcorp LH Stock Holding History

Caxton Associates (UK)’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
11,892
+7,047
+145% +$1.85M 0.06% 145
2026
Q1 		$1.29M Sell
4,845
-1,986
-29% -$538K 0.03% 319
2025
Q4 		$1.71M Hold
6,831
– – 0.03% 239
2025
Q3 		$1.96M Buy
6,831
+4,166
+156% +$1.12M 0.05% 205
2025
Q2 		$700K Sell
2,665
-8,399
-76% -$2.05M 0.02% 367
2025
Q1 		$2.58M Buy
+11,064
New +$2.68M 0.09% 111

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Caxton Associates (UK)'s LH Position: Q2 2026 in Review

Caxton Associates (UK) increased its Labcorp (LH) stake by 145% in Q2 2026, buying an estimated $1.85M and bringing the position to 11,892 shares worth $3.33M. The position accounts for 0.06% of the portfolio, ranked #145.

Caxton Associates (UK) first reported a position in LH in Q1 2025 and has held it in 6 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Caxton Associates (UK) held 11,892 shares of Labcorp worth $3.33M as of Q2 2026.
  • Caxton Associates (UK) bought 7,047 Labcorp shares in Q2 2026, an estimated $1.85M.
  • Labcorp made up 0.06% of Caxton Associates (UK)'s portfolio in Q2 2026, its #145 holding.
  • Caxton Associates (UK) first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.